
Temazepam, sold under the brand name Restoril, is a benzodiazepine sleeping pill. The United States Food and Drug Administration (FDA) label for Restoril indicates it for the short-term treatment of insomnia, generally 7 to 10 days, and the capsules come in 7.5, 15, 22.5, and 30 mg. Many patients have been taking one every night for years.
Like every benzodiazepine, temazepam works by amplifying gamma-aminobutyric acid (GABA), the brain’s main calming signal. The Ashton Manual’s first chapter, on what benzodiazepines do in the body, describes how tolerance to the sleep-inducing effect develops within a few weeks of regular use, as sleep recordings drift back to where they were before the drug. After that point the capsule is doing less to treat the original insomnia and more to hold off the withdrawal insomnia that would arrive without it.
That is physical dependence, and it does not require misuse. In its 2020 boxed-warning update for the whole benzodiazepine class, the FDA stated that physical dependence can occur when these drugs are taken steadily for several days to weeks, even as prescribed. So, how does a person come off of a nightly sleeping pill that the nervous system has come to expect?
A patient who has taken one Restoril capsule at bedtime, as prescribed, for eight years has not done anything wrong. Physical dependence is not addiction. It is a predictable change in the nervous system caused by the medication, and it is treated by reversing that change slowly, not by a treatment model designed for compulsive drug use.
Unfortunately, the search for help often lands on “benzo detox,” a phrase borrowed from addiction treatment facilities, where a fixed short stay and a fast taper are the opposite of what a temazepam-dependent nervous system needs. Safe discontinuation is a gradual, medically supervised taper over months, sometimes longer, with the patient setting the pace.
Fortunately, that kind of taper is well described. The reason it works starts with the drug’s half-life.
Temazepam is short to medium acting. The Ashton Manual’s equivalence table lists its half-life at 8 to 22 hours, and the Restoril label puts the average closer to nine hours. The same table shows that 20 mg of temazepam is roughly equal to 10 mg of diazepam (Valium), so a 30 mg capsule carries about the same benzodiazepine load as 15 mg of diazepam.
That short half-life matters for a drug taken once at bedtime. By the next afternoon most of the dose is gone, and a dependent nervous system may feel the gap as daytime tension, a racing mind toward evening, or a growing certainty that sleep will not come without the capsule. This is interdose withdrawal, and it is easy to mistake for the original insomnia getting worse.
It is also why stopping abruptly is dangerous. Rebound insomnia, anxiety, tremor, and, in some people, seizures can follow a sudden stop or a fast reduction. A seizure is a medical emergency. Call emergency services for a seizure or any other medical emergency, and never stop temazepam cold turkey.
Professor C. Heather Ashton wrote the Ashton Manual, and its Chapter II contains a set of slow withdrawal schedules. Schedule 9 is titled “Withdrawal from temazepam (Restoril) 30mg nightly with diazepam substitution.” It is the reason a temazepam taper so often runs through diazepam.
The shape of the schedule is simple, even if the arithmetic is not. In the first stages, part of the bedtime temazepam is replaced by an equivalent amount of diazepam, a step at a time, each step held for a week or two, until the whole nightly dose is diazepam. Then the diazepam is lowered by a small amount, held, and lowered again, until it reaches zero many months later.
While no analogy is perfect, think of the difference between a tide and a reservoir. Nightly temazepam is a tide, all the way in at midnight and all the way out by the next afternoon, and the nervous system rides that swing every day. Diazepam, with a half-life the Manual lists at 20 to 100 hours, and longer still for its active metabolite, keeps the water level nearly steady, so the taper can lower it an inch at a time without the shoreline visibly moving.
Professor Ashton’s own note on the schedules matters most: they have worked on real people, and they should be adapted to the person. The numbers are an illustration of the shape, not a prescription.
The crossover taper helps patients who feel the daily swing of a short-acting drug, and Dr. Leeds uses it when it fits. Yet, some patients do better staying on temazepam itself and reducing it directly. For them, Dr. Leeds uses hyperbolic dose reductions, the approach described in the Maudsley Deprescribing Guidelines: each cut is a proportion of the current dose rather than a fixed amount, so the steps shrink as the dose falls.
Capsules come in only four strengths, and the smallest, 7.5 mg, is far too large a step near the end of a taper. So, Dr. Leeds often prescribes a compounded oral liquid, prepared by a compounding pharmacy, which allows reductions of a fraction of a milligram. Creams and other topical preparations, which some compounding pharmacies advertise, have no role in a benzodiazepine taper.
Which route is right depends on the person, the dose, how long the drug has been taken, and what other medications are on board. Dr. Leeds also helps patients taper other psychiatric medications, and the order in which they come off matters. The route is decided with the patient, and revised as the taper goes.
The fear most patients bring to a temazepam taper is never sleeping normally again. Rebound insomnia is real. In the first nights after a reduction, sleep may be lighter, later and broken, with vivid dreams as the dreaming sleep that the drug suppressed comes back.
It is unpleasant, and it is temporary. Most reductions settle within a week or two, which is why the Manual holds each step for about that long. If a step does not settle, the answer is to hold longer or to make the next step smaller, never to push through on a calendar.
Symptoms often come in windows and waves, good stretches followed by rough ones, and protracted withdrawal, in which symptoms continue for months after the last dose, is not rare. In fact, this is one of the strongest arguments for going slowly. A nervous system that is never shocked has less to heal from.
Good sleep habits will not lower a dose for anyone, but they make each reduction easier to tolerate. A fixed rise time every day, including weekends, does more for sleep than a fixed bedtime. Morning daylight, a cool dark bedroom, and screens off well before bed all help the body find its own rhythm as the drug is withdrawn.
Caffeine after noon and naps after early afternoon both borrow from the coming night. Alcohol acts on the same GABA receptors as temazepam, so a nightcap during a taper works against the reduction just made, and it should be avoided.
All of it is worth starting before the first reduction, so the taper begins from a steadier baseline.
There is no fixed timeline. Months is typical, and a year or more is not unusual after many years of nightly use or in a patient sensitive to each reduction. The pace is set by how the patient feels, not by a date.
Yes. The crossover taper to diazepam is the Ashton Manual’s approach and suits many patients, but a direct taper of temazepam with hyperbolic reductions and a compounded oral liquid is an alternative Dr. Leeds uses when it fits better.
Yes. Restoril is the brand name and temazepam is the generic name for the same benzodiazepine. The same dependence, the same withdrawal pattern, and the same slow taper apply to both.
Dr. Leeds is an osteopathic physician and deprescribing specialist in Fort Lauderdale, Florida, and he serves on the medical advisory board of the Benzodiazepine Information Coalition. His practice is concierge, not insurance, and provides medically supervised benzodiazepine tapering to patients in Florida only. Care begins with informed consent in the true sense: risks first, the alternatives including waiting, an exit plan from day one, and the right to pause or decline at any point. There is no facility, no fixed schedule, and no meeting attendance, only one physician and one patient deciding each step together. Patients can read more about medically supervised benzodiazepine tapering and the Ashton Manual approach. Contact Dr. Leeds to talk about a temazepam or Restoril taper.
This article is educational. It is not medical advice, and reading it does not create a doctor-patient relationship. Decisions about starting, continuing, or tapering any medication should be made with your own physician.

Mark Leeds, D.O. is an osteopathic physician and deprescribing specialist in Fort Lauderdale, Florida. He helps patients come off benzodiazepines and sleeping pills with a slow, patient-directed taper guided by the Ashton Manual and the Maudsley Deprescribing Guidelines. Physical dependence is not addiction, and a careful taper is measured in months, not days.
Contact Us for expert guidance on safely tapering off benzodiazepines and reclaiming your life.





